Latest news
Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:20:00 GMTUS FDA accepts supplemental Biologics License Application for Merck’s Enflonsia - PMLiVEPMLiVE · Fri, 07 Aug 2026 10:55:00 GMTFDA accepts application to expand Merck's RSV antibody ENFLONSIA into new season - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 14:35:24 GMTEli Lilly Q2'26: Retatrutide heads toward filing amid BLA dispute - AllSciAllSci · Thu, 06 Aug 2026 11:50:52 GMTIf Approved, Botox Would Be First and Only Neurotoxin for Masseter Prominence - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMTTeleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTTeleflex Announces FDA BLA Approval of EZPLAZ Freeze Dried Plasma - FinvizFinviz · Wed, 29 Jul 2026 07:00:00 GMTFDA Accepts biologics license application for DYNE-251, Alzheimer's Association Launches PROTECT-Cog, NeurologyLive Produces Multiple Feature Length Pieces - NeurologyLiveNeurologyLive · Sat, 25 Jul 2026 23:42:59 GMT